Safety and Tolerability of AT-0174 in Adults With Advanced Solid Tumors

by | Oct 21, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Solid Tumor

Interventions: Drug: AT-0174

Sponsors: Antido Therapeutics (Australia) Pty Ltd

Completed Conditions: Advanced Solid Tumor
Interventions: Drug: AT-0174
Sponsors: Antido Therapeutics (Australia) Pty Ltd
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *